Koers Nectar Lifesciences Limited Bombay S.E.
Aandelen
NECLIFE
INE023H01027
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
32,54 INR | -1,90% | -3,89% | +0,75% |
Omzet 2022 | 16,69 mld. 200 mln. 188 mln. | Omzet 2023 | 15,24 mld. 182 mln. 172 mln. | Marktkapitalisatie | 3,58 mld. 42,84 mln. 40,27 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 250 mln. 2,99 mln. 2,81 mln. | Nettowinst (verlies) 2023 | -242 mln. -2,9 mln. -2,72 mln. | EV/omzet 2022 | 0,83 x |
Nettoschuld 2022 | 8,42 mld. 101 mln. 94,75 mln. | Nettoschuld 2023 | 7,36 mld. 88,14 mln. 82,85 mln. | EV/omzet 2023 | 0,72 x |
K/w-verhouding 2022 |
21,5
x | K/w-verhouding 2023 |
-14,8
x | Werknemers | 1.589 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 42,94% |
1 dag | -2,32% | ||
1 week | -3,89% | ||
Lopende maand | +7,61% | ||
1 maand | +2,14% | ||
3 maanden | -4,73% | ||
6 maanden | +32,62% | ||
Lopend jaar | +0,75% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amit Chadah
CEO | Chief Executive Officer | - | 01-01-04 |
Sanjiv Goyal
FOU | Founder | 64 | 27-06-95 |
Sushil Kapoor
DFI | Director of Finance/CFO | 66 | 14-11-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sanjiv Goyal
FOU | Founder | 64 | 27-06-95 |
Ajay Swaroop
BRD | Director/Board Member | 74 | 11-08-10 |
Meena Verma
BRD | Director/Board Member | 53 | 11-02-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 32,54 | -1,90% | 15 877 |
18-04-24 | 33,17 | -2,47% | 13 851 |
16-04-24 | 34,01 | +4,55% | 15 960 |
15-04-24 | 32,53 | -3,50% | 37 541 |
12-04-24 | 33,71 | -3,08% | 64 557 |
uitgestelde koers Bombay S.E., 19 april 2024 om 06:10 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+19,73% | 44,1 mld. | |
+16,20% | 21,97 mld. | |
+7,75% | 13,27 mld. | |
+6,06% | 13,22 mld. | |
+33,60% | 11,36 mld. | |
-10,59% | 7,07 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+7,71% | 5,23 mld. |
- Beurs
- Aandelen
- Koers NECLIFE
- Koers NECLIFE